Michael Saylor: Bitcoin as Insulin for Corporate Diabetes

3 Min Read Tags:

  • Michael Saylor compares Bitcoin to insulin for companies suffering from “corporate diabetes”.
  • He advocates for adopting the Bitcoin standard as a financial strategy to prevent capital depletion.
  • The current economic environment causes companies to lose 10% of their capital annually.
  • Bitcoin is presented as a resilient and reliable treasury reserve asset, unlike traditional securities.
  • Saylor emphasizes that Bitcoin’s decentralized nature makes it immune to governmental or corporate censorship.

Bitcoin: The Insulin for Corporate Health

In an intriguing comparison, Michael Saylor, the co-founder and CEO of Strategy (formerly MicroStrategy), likens Bitcoin to insulin necessary for treating “corporate diabetes”. During a discussion titled “Why the Bitcoin Standard Matters”, Saylor stressed the importance of adopting a Bitcoin standard for corporations. He shared this platform with Jeff Park from Bitwise and Larry Cermak, CEO of The Block.
Saylor argues that modern businesses are depleting themselves by holding short-term treasury bonds that yield only 2-3% after taxes, while their cost of capital stands at 12%. This results in an annual loss of 10% in capital value, likened to “starving while eating”.

The Necessity of Capital Preservation

According to Saylor, just as insulin is vital for individuals with Type I diabetes, sufficient capital is crucial for corporate prosperity. Without a sound financial strategy akin to insulin management in diabetes care, companies struggle to maintain their economic energy.
Adopting the Bitcoin standard can significantly enhance a company’s attractiveness to investors. This increased investment leads to higher shareholder value and strengthens the company’s market position.

Bitcoin: A Resilient Reserve Asset

Saylor highlights that Bitcoin marks a breakthrough asset class in over a century, being neither a security nor yielding returns lower than its cost. Its decentralized nature renders it resistant to destruction by any state or capitalist entities.
He dispels myths labeling Bitcoin as an unproductive asset and criticizes its sole use as a fiat profit tool. Exchanging dollar stocks for appreciating Bitcoin assets generates real shareholder value.

Beyond Other Cryptocurrencies

Saylor warns against replicating Strategy’s approach with other cryptocurrencies like Ethereum or Solana. He compares Bitcoin’s foundational strength to steel, while others resemble balsa wood—unsuitable for foundations.
In March 2025, Saylor proposed creating an $81 trillion US government-backed Bitcoin reserve plan.
With these insights from Michael Saylor on leveraging cryptocurrency strategically within corporate finance frameworks, businesses can explore innovative pathways toward sustainable growth and profitability.

Anthropic Files for IPO on Nasdaq

Anthropic said on October 26, 2026, that it filed an S-1 with the SEC for a Nasdaq IPO under ticker ANT, led by Goldman Sachs and Morgan Stanley, with terms…

3 Min Read
Keystone Reports Customer Data Leak Affecting Hardware Crypto Wallet Users

Keystone said on Oct. 23, 2026, that a third party’s unauthorized website access exposed customers’ personal and order information, but not payment data, wallet passwords, private keys or seed phrases.

3 Min Read
Bitcoin Draws Record Retail Inflows as Experts See $70,000 Support

CryptoQuant said 30-day retail bitcoin inflows to Binance rose from $5.5 billion to a six-month high of $10.75 billion, while whale inflows fell and traders’ $70,000 realized price could support…

4 Min Read
Argentine Court Drops LIBRA Criminal Case Against Javier Milei, 10 Others

An Argentine federal court dismissed the criminal case against President Javier Milei, his sister Karina Milei and nine others over LIBRA’s collapse, finding insufficient evidence of fraud, corruption or other…

5 Min Read
Bitcoin Hits $79,500 Target as Ethereum Faces Pressure Before Fed Meeting

An unnamed trader said a Bitcoin short reached its final $79,500 target, while an October close below $80,000 could open a decline toward $72,500 and $70,000.

6 Min Read